tiprankstipranks
BioMarin price target raised to $110 from $100 at Wells Fargo
PremiumThe FlyBioMarin price target raised to $110 from $100 at Wells Fargo
6d ago
BioMarin raises FY24 adjusted EPS view to $2.75-$2.95 from $2.60-$280
PremiumThe Fly
BioMarin raises FY24 adjusted EPS view to $2.75-$2.95 from $2.60-$280
7d ago
BioMarin reports Q1 non-GAAP EPS 71c, consensus 34c
PremiumThe Fly
BioMarin reports Q1 non-GAAP EPS 71c, consensus 34c
7d ago
BioMarin participates in a conference call with JPMorgan.
PremiumThe FlyBioMarin participates in a conference call with JPMorgan.
19d ago
BioMarin participates in a conference call with JPMorgan.
PremiumThe Fly
BioMarin participates in a conference call with JPMorgan.
20d ago
BioMarin participates in a conference call with JPMorgan.
PremiumThe Fly
BioMarin participates in a conference call with JPMorgan.
20d ago
New Share Price & Shareholder Rights Risk for Biomarin Pharmaceutical Inc. – What’s the Latest?
PremiumCompany AnnouncementsNew Share Price & Shareholder Rights Risk for Biomarin Pharmaceutical Inc. – What’s the Latest?
2M ago
BioMarin discloses receipt of subpoena from U.S. Department of Justice
PremiumThe Fly
BioMarin discloses receipt of subpoena from U.S. Department of Justice
2M ago
BioMarin price target lowered to $107 from $115 at Piper Sandler
PremiumThe Fly
BioMarin price target lowered to $107 from $115 at Piper Sandler
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100